Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss

Group 1 - A class action lawsuit has been filed against iRhythm Technologies, Inc. on behalf of shareholders who purchased stock between January 11, 2022, and May 30, 2023 [1] - The lawsuit alleges that iRhythm misrepresented the capabilities of its Zio AT monitor, claiming it was a real-time monitor for high-risk patients, while its main product, Zio XT, was intended for non-critical patients without real-time reporting [2] - The stock price of iRhythm was artificially inflated due to these representations, and it declined when the truth about the product's capabilities was revealed [2] Group 2 - On June 3, 2025, Judge Jacqueline S. Corley partially granted and denied the defendants' motion to dismiss, allowing litigation against iRhythm and its CEO to proceed [3] - Shareholders of iRhythm Technologies, Inc. have legal options available to them following the class action filing [3]